Abstract:THE ROLE OF p62 IN OSTEOCLASTOGENESIS AND PAGET’S DISEASE OF BONE by Tamer M. A. Hadi, M.S., Ph.D. A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy at Virginia Commonwealth University, 2014 Director: Jolene J. Windle, Ph.D. Irene Shaw Grigg Distinguished Professor, Department of Molecular and Human Genetics Director, VCU Transgenic/Knock-out Mouse Core Cancer Molecular Genetics Program Co-leader, Massey Cancer Center Paget’s disease (PDB) is the second most common metabolic bone disease after osteoporosis, affecting up to 3% of adults over age 55. It is characterized by focal lesions of bone resorbed by hyperactive osteoclasts coupled with rapid formation of highly disorganized, low quality bone formed by osteoblasts. Such lesions cause skeletal deformity, fractures, and other symptoms that significantly decrease quality of life. In 2001, mutations in the SQSTM1/p62 gene were found in a subset of Paget’s patients. The work summarized in this dissertation sought to answer two broad questions: what is the function of p62 in normal bone homeostasis and how do PDB-associated mutations alter it? These studies took advantage of two mouse models: p62 knock-out (KO) mice, and p62P394L “knock-in” (KI) mice carrying the most common PDB-associated mutation. KO, KI, and wildtype (WT) controls were aged to one year for skeletal-histological characterization. No differences were observed in a variety of bone parameters between WT and KO bones, while bones from age-matched KI mice exhibited a 33% decrease in bone volume and a 25% increase in osteoclast formation. In vivo, TNF-α caused a potent induction of osteoclastogenesis in calvariae of WT and KI, but not KO, mice. In vitro, RANKL induced osteoclast formation in a dose-dependent manner in WT and KI, but not KO, cultures. Gene expression profiling of RANKL-treated osteoclast progenitors from WT, KO, and KI mice was then performed to identify the changes in signaling pathways responsible for these effects. Surprisingly, gene expression patterns from all three groups were consistent with robust activation of NFκB signaling in RANKL-treated samples, indicating that p62 is dispensable for RANKL activation of NFκB. Interestingly, gene expression patterns in KO cells suggested impaired proliferation and response to reactive oxygen species (ROS), a finding which was confirmed in cell culture experiments. In contrast, KI cells displayed enrichment for genes associated with the unfolded protein response, consistent with p62’s role in ubiquitin-mediated protein degradation via proteolysis and autophagy. These studies have therefore generated several novel hypotheses concerning the role of p62 in both normal bone homeostasis and Paget’s disease of bone.

A FKBP5 Mutation is Associated with Paget's Disease of Bone and Enhances Osteoclastogenesis

C/Ebp Alpha Regulates Osteoclast Lineage Commitment

Mutations in Profilin 1 Cause Early-Onset Paget's Disease of Bone with Giant Cell Tumors.

Clinical, Biochemical, Radiological, and Genetic Analyses of a Patient with VCP Gene Variant-Induced Paget's Disease of Bone

Clinical Characteristics and Pathogenic Gene Identification in Chinese Patients with Paget's Disease of Bone

Thirteen Chinese patients with sporadic Paget’s disease of bone: clinical features, SQSTM1 mutation identification, and functional analysis

Paget's disease of bone: evidence for complex pathogenetic interactions

Identification of a Novel Mutation (78dup27) of the TNFRSF11A Gene in a Chinese Family with Early Onset Paget's Disease of Bone

Clinical and Genetic Advances in Paget's Disease of Bone: a Review

Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone

Identification and Molecular Characterization of a Novel Splice-Site Mutation (G1205C) in the SQSTM1 Gene Causing Paget’s Disease of Bone in an Extended American Family

New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's disease of bone.

Conditional Knockout of PKC- in Osteoclasts Favors Bone Mass Accrual in Males Due to Decreased Osteoclast Function

CXCL5 stimulation of RANK ligand expression in Paget's disease of bone

Characterization of A Relatively Malignant Form of Osteopetrosis Caused by A Novel Mutation in the Plekhm1 Gene

Mutation analysis of SQSTM1 and TNFRSF11A genes in a Chinese family with Paget disease of bone

Global deletion of Optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget’s disease

Exome Sequencing Reveals a Phenotype Modifying Variant in ZNF528 in Primary Osteoporosis with a COL1A2 Deletion.

The adaptor protein p62/SQSTM1 in osteoclast signaling pathways

THE ROLE OF p62 IN OSTEOCLASTOGENESIS AND PAGET’S DISEASE OF BONE

Early identification of a 12-bp tandem duplication in TNFRSF11A encoding receptor activator of nuclear factor-kappa B (RANK): Clinical characterization and response to bisphosphonate therapy